Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay

Journal of Clinical Virology

Volumn 29, Issue 1, 2004, Pages 33-38

  Fondere, Jean Michel ^a   Planas, Jean François ^a   Huguet, Marie France ^a   Baillat, Vincent ^b   Bolos, Frederic ^a   Reynes, Jacques ^b   Vendrell, Jean Pierre ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

ELISPOT assay; HAART; HIV 1 cell reservoir

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HYDROXYUREA; INDINAVIR; LAMIVUDINE; MONOCLONAL ANTIBODY CD3; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0346220188     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00083-0     Document Type: Article

References (22)

1. Briant L., Reynes J., Coudronniere N., Benezech J.P., Devaux C. HIV-1 reactivation in resting peripheral blood mononuclear cells of infected adults upon in vitro CD4 cross-linking by ligands of the CDR2-loop in extracellular domain 1. J. Acquired Immune Defic. Syndromes. 21:1999;9-19.
2. Bukrinsky M.I., Stanwick T.L., Dempsey M.P., Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science. 254:1991;423-427.
3. Bukrinsky M.I., Sharova N., Denpsey M.P., Dempsey M.P., Stanwick T.L., Bukrinskaya A.G. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. 89:1992;6580-6584.
4. Chun T.W., Carruth L., Finzi D., Shen X., DiGiuseppe J.A., Taylor H., et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387:1997;183-188.
5. Chun T.W., Engel D., Berrey M.M., Shea T., Corey L., Fauci A.S. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. 95:1998;8869-8873.
6. + T cells using a combination of cytokines. J. Exp. Med. 188:1998;83-91.
7. Corne P., Huguet M.F., Briant L., Segondy M., Reynes J., Vendrell J.P. Detection and enumeration of HIV-1-producing cells by ELISPOT (enzyme-linked immunospot) assay. J. Acquired Immune Defic. Syndrome. 20:1999;442-447.
8. Czerkinsky C.C., Nilsson L.A., Nygren H., Ouchterlony O., Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods. 65:1983;109-121.
9. Derdeyn C.A., Kilby J.M., Miralles G.D., Li L.F., Sfakianos G., Saag M.S., et al. Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy. J. Infect. Dis. 180:1999;1851-1862.
10. Finzi D., Hermankova M., Pierson T., Carruth L.M., Buck C., Chaisson R.E., et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 278:1997;1295-1300.
11. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:1999;512-517.
12. Foudraine N.A., Hoetelmans R.M., Lange J.M., de Wolf F., van Benthem B.H., Maas J.J., et al. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet. 351:1998;1547-1551.
13. Kitchen S.G., Korin Y.D., Roth M.D., Landay A., Zack J.A. Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J. Virol. 72:1998;9054-9060.
14. Kravcik S., Gallicano K., Roth V., Cassol S., Hawley-Foss N., Badley A., et al. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. J. Acquired Immune Defic. Syndrome. 21:1999;371-375.
15. Ho D.D. Toward HIV eradication or remission: the tasks ahead. Science. 280:1998;1866-1867.
16. Moir S., Malaspina A., Li Y., Chun T.W., Lowe T., Adelsberger J., et al. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J. Exp. Med. 19:2000;637-646.
17. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cells life-span, and viral generation time. Science. 271:1996;1582-1586.
18. Ramratnam B., Mittler J.E., Zhang L., Boden D., Hurley A., Fang F., Macken C.A., et al. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat. Med. 6:2000;82-85.
19. Si-Mohamed A., Kazatchkine M.D., Heard I., Goujon C., Prazuck T., Aymard G., et al. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J. Infect. Dis. 182:2000;112-122.
20. Sonza S., Mutimer H.P., Oelrichs R., Jardine D., Harvey K., Dunne A., et al. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS. 15:2001;17-22.
21. Tamalet C., Lafeuillade A., Fantini J., Poggi C., Yahi N. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. AIDS. 11:1997;895-901.
22. Zack J.A., Arrigo S.J., Weitsman S.R., Go A.S., Haislip A., Chen I.S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 61:1990;213-222.